Charles Simone
Professor and Chief Medical Officer
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Charles Simone is a Professor and Chief Medical Officer at the New York Proton Center in the United States. His research focuses on radiotherapy advancements, particularly in the treatment of malignancies such as lung cancer and prostate cancer. He has contributed to various articles examining topics such as the integration of immunotherapy, the application of artificial intelligence in cancer assessment, and the impact of proton therapy on treatment side effects.
Articles (25)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Bragg peak FLASH radiotherapy (RT) uses a distal tracking method to eliminate exit doses and can achieve superior OAR sparing. This study explores the application of this novel method in stereotactic body radiotherapy prostate FLASH-RT. An in-house platform was developed to enable intensity-modulated proton therapy (IMPT) planning using a single-energy Bragg peak distal tracking method. The patients involved in the study were previously treated with proton stereotactic body radiotherapy (SBRT) using the pencil beam scanning (PBS) technique to 40 Gy in five fractions. FLASH plans were optimized using a four-beam arrangement to generate a dose distribution similar to the conventional opposing beams. All of the beams had a small angle of two degrees from the lateral direction to increase the dosimetry quality. Dose metrics were compared between the conventional PBS and the Bragg peak FLASH plans. The dose rate histogram (DRVH) and FLASH metrics of 40 Gy/s coverage (V40Gy/s) were investigated for the Bragg peak plans. There was no significant difference between the clinical and Bragg peak plans in rectum, bladder, femur heads, large bowel, and penile bulb dose metrics, except for Dmax. For the CTV, the FLASH plans resulted in a higher Dmax than the clinical plans (116.9% vs. 103.3%). For the rectum, the V40Gy/s reached 94% and 93% for 1 Gy dose thresholds in composite and single-field evaluations, respectively. Additionally, the FLASH ratio reached close to 100% after the application of the 5 Gy threshold in composite dose rate assessment. In conclusion, the Bragg peak distal tracking method can yield comparable plan quality in most OARs while preserving sufficient FLASH dose rate coverage, demonstrating that the ultra-high dose technique can be applied in prostate FLASH SBRT.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Collaborators (10)
Liyong Lin
Adjunct Associate Professor
Georgia Institute of Technology
Jenghwa Chang
Hofstra University
Andrea Riccardo Filippi
Full Professor
University of Pavia
Michael Lock
Western University
Minglei Kang
Associate Professor, Director of Proton Physics
University of Wisconsin-Madison
Dale Lovelock
Mount Sinai Hospital
Ying Xiao
Professor, Clinician-Educator
University of Pennsylvania
Chin-Cheng Chen
Chief Clinical Physicis
St. Jude Children's Research Hospital
Robert Griffin
University of Arkansas for Medical Sciences
Wei Liu
Professor
Mayo Clinic Arizona
Make your next move.
Prepare your application
Review drafts before you send them.